Position in RYTM
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$234,495
-$13,195 QoQ
Shares Held
2,112
-25.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#218
of 299 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CIBC Asset Management Inc holds $114,884,709 across 45 Biotechnology names. RYTM ranks #30 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
104,292 | $51,804,965 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,660 | $25,976,676 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,342 | $8,832,822 | |
| 4 | INCY |
Incyte Corp
|
63,141 | $7,157,663 | |
| 5 | MRNA |
Moderna, Inc.
|
78,815 | $5,519,414 | |
| 6 | TECH |
BIO-TECHNE Corp
|
34,505 | $2,437,778 | |
| 7 | RPRX |
Royalty Pharma plc
|
34,087 | $1,911,258 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
8,768 | $1,642,071 |
All Filings in RYTM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $234,495 | 2,112 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $247,690 | 2,848 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $304,849 | 2,848 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||